Switch to:
Also traded in: Argentina, Germany, Mexico

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.23
CAH's Cash-to-Debt is ranked lower than
78% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.69 vs. CAH: 0.23 )
Ranked among companies with meaningful Cash-to-Debt only.
CAH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.42 Max: 3.34
Current: 0.23
0
3.34
Equity-to-Asset 0.18
CAH's Equity-to-Asset is ranked lower than
91% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.44 vs. CAH: 0.18 )
Ranked among companies with meaningful Equity-to-Asset only.
CAH' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.16  Med: 0.35 Max: 0.5
Current: 0.18
0.16
0.5
Debt-to-Equity 1.27
CAH's Debt-to-Equity is ranked lower than
84% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.56 vs. CAH: 1.27 )
Ranked among companies with meaningful Debt-to-Equity only.
CAH' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04  Med: 0.46 Max: 1.53
Current: 1.27
0.04
1.53
Debt-to-EBITDA 3.16
CAH's Debt-to-EBITDA is ranked lower than
75% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.37 vs. CAH: 3.16 )
Ranked among companies with meaningful Debt-to-EBITDA only.
CAH' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.22  Med: 1.68 Max: 3.51
Current: 3.16
0.22
3.51
Interest Coverage 6.45
CAH's Interest Coverage is ranked lower than
67% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.71 vs. CAH: 6.45 )
Ranked among companies with meaningful Interest Coverage only.
CAH' s Interest Coverage Range Over the Past 10 Years
Min: 6.45  Med: 14.03 Max: 19.27
Current: 6.45
6.45
19.27
Piotroski F-Score: 7
Altman Z-Score: 3.98
Beneish M-Score: -2.50
WACC vs ROIC
7.18%
20.55%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 1.53
CAH's Operating Margin % is ranked lower than
69% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.60 vs. CAH: 1.53 )
Ranked among companies with meaningful Operating Margin % only.
CAH' s Operating Margin % Range Over the Past 10 Years
Min: 1.39  Med: 1.71 Max: 2.14
Current: 1.53
1.39
2.14
Net Margin % 1.26
CAH's Net Margin % is ranked lower than
59% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.61 vs. CAH: 1.26 )
Ranked among companies with meaningful Net Margin % only.
CAH' s Net Margin % Range Over the Past 10 Years
Min: 0.33  Med: 1.08 Max: 1.49
Current: 1.26
0.33
1.49
ROE % 24.06
CAH's ROE % is ranked higher than
90% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.39 vs. CAH: 24.06 )
Ranked among companies with meaningful ROE % only.
CAH' s ROE % Range Over the Past 10 Years
Min: 5.47  Med: 17.46 Max: 24.06
Current: 24.06
5.47
24.06
ROA % 4.24
CAH's ROA % is ranked higher than
59% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.37 vs. CAH: 4.24 )
Ranked among companies with meaningful ROA % only.
CAH' s ROA % Range Over the Past 10 Years
Min: 1.33  Med: 4.46 Max: 5.58
Current: 4.24
1.33
5.58
ROC (Joel Greenblatt) % 57.80
CAH's ROC (Joel Greenblatt) % is ranked higher than
83% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.92 vs. CAH: 57.80 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
CAH' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 21.1  Med: 62.14 Max: 122.97
Current: 57.8
21.1
122.97
3-Year Revenue Growth Rate 15.40
CAH's 3-Year Revenue Growth Rate is ranked higher than
70% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.70 vs. CAH: 15.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
CAH' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -4.7  Med: 13.5 Max: 43.9
Current: 15.4
-4.7
43.9
3-Year EBITDA Growth Rate 10.40
CAH's 3-Year EBITDA Growth Rate is ranked higher than
54% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.60 vs. CAH: 10.40 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
CAH' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -10.3  Med: 10.8 Max: 84.5
Current: 10.4
-10.3
84.5
3-Year EPS without NRI Growth Rate 6.10
CAH's 3-Year EPS without NRI Growth Rate is ranked higher than
50% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.10 vs. CAH: 6.10 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
CAH' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -15.7  Med: 13.4 Max: 64.5
Current: 6.1
-15.7
64.5
GuruFocus has detected 2 Warning Signs with Cardinal Health Inc CAH.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CAH's 30-Y Financials

Financials (Next Earnings Date: 2018-08-02)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2017

CAH Guru Trades in Q2 2017

Manning & Napier Advisors, Inc 68,883 sh (New)
Charles Brandes 31,619 sh (New)
Steven Cohen 634,145 sh (New)
David Dreman 12,233 sh (New)
Seth Klarman 2,030,000 sh (+97.09%)
Vanguard Health Care Fund 7,522,531 sh (+18.94%)
Mairs and Power 3,434 sh (+15.20%)
John Buckingham 22,297 sh (+12.19%)
Barrow, Hanley, Mewhinney & Strauss 20,846,948 sh (+0.69%)
Pioneer Investments Sold Out
Ray Dalio Sold Out
Richard Pzena 1,058,804 sh (-0.05%)
Arnold Van Den Berg 91,167 sh (-1.62%)
John Rogers 661,475 sh (-11.42%)
First Pacific Advisors 52,300 sh (-42.21%)
» More
Q3 2017

CAH Guru Trades in Q3 2017

Paul Tudor Jones 8,145 sh (New)
Charles Brandes 698,546 sh (+2109.26%)
Richard Pzena 1,806,522 sh (+70.62%)
Steven Cohen 880,858 sh (+38.90%)
Seth Klarman 2,530,000 sh (+24.63%)
John Rogers 735,687 sh (+11.22%)
Vanguard Health Care Fund 7,865,646 sh (+4.56%)
Mairs and Power 3,434 sh (unchged)
David Dreman 12,233 sh (unchged)
Arnold Van Den Berg Sold Out
John Buckingham 21,487 sh (-3.63%)
Barrow, Hanley, Mewhinney & Strauss 20,051,896 sh (-3.81%)
Manning & Napier Advisors, Inc 63,515 sh (-7.79%)
First Pacific Advisors 43,000 sh (-17.78%)
» More
Q4 2017

CAH Guru Trades in Q4 2017

Pioneer Investments 1,827,056 sh (New)
Ray Dalio 475,692 sh (New)
Jim Simons 77,900 sh (New)
Larry Robbins 751,018 sh (New)
Joel Greenblatt 277,754 sh (New)
Seth Klarman 5,100,000 sh (+101.58%)
Charles Brandes 1,252,911 sh (+79.36%)
John Rogers 861,809 sh (+17.14%)
Richard Pzena 1,950,460 sh (+7.97%)
John Buckingham 22,478 sh (+4.61%)
Steven Cohen 51,400 sh (unchged)
First Pacific Advisors Sold Out
Paul Tudor Jones Sold Out
Mairs and Power 3,344 sh (-2.62%)
Vanguard Health Care Fund 7,572,246 sh (-3.73%)
Barrow, Hanley, Mewhinney & Strauss 17,876,233 sh (-10.85%)
Steven Cohen 316,500 sh (-64.07%)
David Dreman 590 sh (-95.18%)
» More
Q1 2018

CAH Guru Trades in Q1 2018

Larry Robbins 3,016,195 sh (+301.61%)
Steven Cohen 1,266,327 sh (+300.10%)
Richard Pzena 2,873,639 sh (+47.33%)
Ray Dalio 606,782 sh (+27.56%)
Barrow, Hanley, Mewhinney & Strauss 18,582,776 sh (+3.95%)
David Dreman 590 sh (unchged)
Seth Klarman 5,100,000 sh (unchged)
Jim Simons Sold Out
Joel Greenblatt Sold Out
John Buckingham 22,377 sh (-0.45%)
John Rogers 850,845 sh (-1.27%)
Pioneer Investments 1,787,229 sh (-2.18%)
Mairs and Power 3,244 sh (-2.99%)
Charles Brandes 1,204,802 sh (-3.84%)
Vanguard Health Care Fund 6,936,246 sh (-8.40%)
» More
» Details

Insider Trades

Latest Guru Trades with NYSE:CAH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Barrow, Hanley, Mewhinney & Strauss 2018-03-31 Add 3.95%0.07%$61.22 - $75.23 $ 53.33-22%18,582,776
Vanguard Health Care Fund 2018-03-31 Reduce -8.40%0.08%$61.22 - $75.23 $ 53.33-22%6,936,246
Richard Pzena 2018-03-31 Add 47.33%0.3%$61.22 - $75.23 $ 53.33-22%2,873,639
Charles Brandes 2018-03-31 Reduce -3.84%0.06%$61.22 - $75.23 $ 53.33-22%1,204,802
John Rogers 2018-03-31 Reduce -1.27%0.01%$61.22 - $75.23 $ 53.33-22%850,845
Joel Greenblatt 2018-03-31 Sold Out 0.25%$61.22 - $75.23 $ 53.33-22%0
Barrow, Hanley, Mewhinney & Strauss 2017-12-31 Reduce -10.85%0.2%Premium Member Access $61.27 $ 53.33-13%17,876,233
Barrow, Hanley, Mewhinney & Strauss 2017-12-31 Reduce -10.85%0.22%$55 - $68.24 $ 53.33-14%17,876,233
Vanguard Health Care Fund 2017-12-31 Reduce -3.73%0.04%$55 - $68.24 $ 53.33-14%7,572,246
Seth Klarman 2017-12-31 Add 101.58%1.56%$55 - $68.24 $ 53.33-14%5,100,000
Richard Pzena 2017-12-31 Add 7.97%0.04%$55 - $68.24 $ 53.33-14%1,950,460
Charles Brandes 2017-12-31 Add 79.36%0.69%$55 - $68.24 $ 53.33-14%1,252,911
John Rogers 2017-12-31 Add 17.14%0.09%$55 - $68.24 $ 53.33-14%861,809
Joel Greenblatt 2017-12-31 New Buy0.25%$55 - $68.24 $ 53.33-14%277,754
David Dreman 2017-12-31 Reduce -95.18%0.43%$55 - $68.24 $ 53.33-14%590
Barrow, Hanley, Mewhinney & Strauss 2017-09-30 Reduce -3.81%0.09%$64.36 - $78.69 $ 53.33-25%20,051,896
Vanguard Health Care Fund 2017-09-30 Add 4.56%0.05%$64.36 - $78.69 $ 53.33-25%7,865,646
Seth Klarman 2017-09-30 Add 24.63%0.42%$64.36 - $78.69 $ 53.33-25%2,530,000
Richard Pzena 2017-09-30 Add 70.62%0.26%$64.36 - $78.69 $ 53.33-25%1,806,522
John Rogers 2017-09-30 Add 11.22%0.06%$64.36 - $78.69 $ 53.33-25%735,687
Charles Brandes 2017-09-30 Add 2109.26%0.91%$64.36 - $78.69 $ 53.33-25%698,546
Arnold Van Den Berg 2017-09-30 Sold Out 1.11%$64.36 - $78.69 $ 53.33-25%0
Barrow, Hanley, Mewhinney & Strauss 2017-06-30 Add 0.69%0.02%$71.6 - $82.71 $ 53.33-29%20,846,948
Vanguard Health Care Fund 2017-06-30 Add 18.94%0.2%$71.6 - $82.71 $ 53.33-29%7,522,531
Seth Klarman 2017-06-30 Add 97.09%0.9%$71.6 - $82.71 $ 53.33-29%2,030,000
Richard Pzena 2017-06-30 Reduce -0.05%$71.6 - $82.71 $ 53.33-29%1,058,804
John Rogers 2017-06-30 Reduce -11.42%0.08%$71.6 - $82.71 $ 53.33-29%661,475
Arnold Van Den Berg 2017-06-30 Reduce -1.62%0.02%$71.6 - $82.71 $ 53.33-29%91,167
Charles Brandes 2017-06-30 New Buy0.04%$71.6 - $82.71 $ 53.33-29%31,619
David Dreman 2017-06-30 New Buy0.52%$71.6 - $82.71 $ 53.33-29%12,233
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Distribution » Medical Distribution    NAICS: 424210    SIC: 5122
Compare:NYSE:ABC, XKRX:091990, NAS:HSIC, HKSE:01099, SHSE:601607, NYSE:MCK, TSE:7459, SZSE:002589, SHSE:600056, SZSE:200028, LSE:UDG, SHSE:600763, NAS:PDCO, NZSE:EBO, SHSE:600090, NYSE:PBH, LSE:CLIN, SHSE:603368, TSE:7476, NYSE:OMI » details
Traded in other countries:CAH.Argentina, CLH.Germany, CAH.Mexico,
Headquarter Location:USA
Cardinal Health Inc is a healthcare services company. It provides services and products for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices.

Cardinal Health is a major distributor of pharmaceuticals and medical supplies to pharmacies and hospitals. Its operations include procurement, packaging, inventory management, and logistics services. Its largest customer is CVS Health retail pharmacy operations.

Top Ranked Articles about Cardinal Health Inc

Cardinal Health Board of Directors Approves Quarterly Dividend
Stocks That Fell to 3-Year Lows in the Week of May 4 AT&T Inc., Gilead Sciences Inc., CVS Health Corp., and Cardinal Health Inc. have declined to their respective three-year lows
AT&T Inc. (NYSE:T), Gilead Sciences Inc. (NASDAQ:GILD), CVS Health Corp. (NYSE:CVS) and Cardinal Health Inc. (NYSE:CAH) have declined to their three-year lows. Read more...
Cardinal Health urEssential Award Recognizes Laboratory Professor's Distinguished Career
The Kroger Co. and Cardinal Health to Co-Host Drug Take-Back Events Across 26 States on April 28
Cardinal Health Donates 16,000 Drug Disposal Envelopes to the National Community Pharmacists Association Foundation
5 Companies Raising Their Revenue and Earnings Lear Corp, L Brands on the list
According to the GuruFocus All-In-One Screener, the following companies have grown their revenues and earnings over the past several years. Read more...
Cardinal Health Begins Donation of Over 80,000 Doses of Life-Saving Narcan® for Distribution to Law Enforcement and First Responders in Appalachia
Cardinal Health to Webcast Discussion of Third-Quarter Results for Fiscal Year 2018 on May 3
Survey Finds 40 Percent of Health Care Providers Have Canceled Surgical Cases Due to Lack of Supplies
Cardinal Health Highlights Commitment To Gender Equity As Part Of Women's History Month Celebrations

Ratios

vs
industry
vs
history
PE Ratio 9.94
CAH's PE Ratio is ranked higher than
81% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.00 vs. CAH: 9.94 )
Ranked among companies with meaningful PE Ratio only.
CAH' s PE Ratio Range Over the Past 10 Years
Min: 6.29  Med: 15.74 Max: 73.78
Current: 9.94
6.29
73.78
Forward PE Ratio 9.71
CAH's Forward PE Ratio is ranked higher than
69% of the 13 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.99 vs. CAH: 9.71 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 9.94
CAH's PE Ratio without NRI is ranked higher than
83% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.94 vs. CAH: 9.94 )
Ranked among companies with meaningful PE Ratio without NRI only.
CAH' s PE Ratio without NRI Range Over the Past 10 Years
Min: 9.89  Med: 18.61 Max: 74.54
Current: 9.94
9.89
74.54
Price-to-Owner-Earnings 7.99
CAH's Price-to-Owner-Earnings is ranked lower than
54% of the 35 Companies
in the Global Medical Distribution industry.

( Industry Median: 18.94 vs. CAH: 7.99 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
CAH' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 6.22  Med: 14.74 Max: 58.55
Current: 7.99
6.22
58.55
PB Ratio 2.23
CAH's PB Ratio is ranked lower than
66% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.12 vs. CAH: 2.23 )
Ranked among companies with meaningful PB Ratio only.
CAH' s PB Ratio Range Over the Past 10 Years
Min: 0.86  Med: 2.54 Max: 4.76
Current: 2.23
0.86
4.76
PS Ratio 0.13
CAH's PS Ratio is ranked higher than
84% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.91 vs. CAH: 0.13 )
Ranked among companies with meaningful PS Ratio only.
CAH' s PS Ratio Range Over the Past 10 Years
Min: 0.08  Med: 0.16 Max: 0.32
Current: 0.13
0.08
0.32
Price-to-Free-Cash-Flow 6.52
CAH's Price-to-Free-Cash-Flow is ranked higher than
60% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.20 vs. CAH: 6.52 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
CAH' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 5.82  Med: 11.84 Max: 43.13
Current: 6.52
5.82
43.13
Price-to-Operating-Cash-Flow 5.77
CAH's Price-to-Operating-Cash-Flow is ranked higher than
55% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.02 vs. CAH: 5.77 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CAH' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 4.68  Med: 10.16 Max: 24.47
Current: 5.77
4.68
24.47
EV-to-EBIT 11.65
CAH's EV-to-EBIT is ranked lower than
69% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.52 vs. CAH: 11.65 )
Ranked among companies with meaningful EV-to-EBIT only.
CAH' s EV-to-EBIT Range Over the Past 10 Years
Min: 4.8  Med: 11.4 Max: 15.4
Current: 11.65
4.8
15.4
EV-to-EBITDA 7.93
CAH's EV-to-EBITDA is ranked higher than
50% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.88 vs. CAH: 7.93 )
Ranked among companies with meaningful EV-to-EBITDA only.
CAH' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.1  Med: 9.1 Max: 12.5
Current: 7.93
4.1
12.5
EV-to-Revenue 0.18
CAH's EV-to-Revenue is ranked higher than
84% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.93 vs. CAH: 0.18 )
Ranked among companies with meaningful EV-to-Revenue only.
CAH' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.1  Med: 0.2 Max: 0.3
Current: 0.18
0.1
0.3
PEG Ratio 1.06
CAH's PEG Ratio is ranked higher than
79% of the 28 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.54 vs. CAH: 1.06 )
Ranked among companies with meaningful PEG Ratio only.
CAH' s PEG Ratio Range Over the Past 10 Years
Min: 1.06  Med: 2.12 Max: 10.28
Current: 1.06
1.06
10.28
Shiller PE Ratio 15.31
CAH's Shiller PE Ratio is ranked higher than
62% of the 21 Companies
in the Global Medical Distribution industry.

( Industry Median: 27.63 vs. CAH: 15.31 )
Ranked among companies with meaningful Shiller PE Ratio only.
CAH' s Shiller PE Ratio Range Over the Past 10 Years
Min: 6.64  Med: 15.19 Max: 29.01
Current: 15.31
6.64
29.01
Current Ratio 1.10
CAH's Current Ratio is ranked lower than
87% of the 54 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.50 vs. CAH: 1.10 )
Ranked among companies with meaningful Current Ratio only.
CAH' s Current Ratio Range Over the Past 10 Years
Min: 1.06  Med: 1.52 Max: 2.99
Current: 1.1
1.06
2.99
Quick Ratio 0.54
CAH's Quick Ratio is ranked lower than
93% of the 54 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.12 vs. CAH: 0.54 )
Ranked among companies with meaningful Quick Ratio only.
CAH' s Quick Ratio Range Over the Past 10 Years
Min: 0.42  Med: 0.66 Max: 1.46
Current: 0.54
0.42
1.46
Days Inventory 33.88
CAH's Days Inventory is ranked higher than
60% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 41.27 vs. CAH: 33.88 )
Ranked among companies with meaningful Days Inventory only.
CAH' s Days Inventory Range Over the Past 10 Years
Min: 25.37  Med: 30.84 Max: 35.34
Current: 33.88
25.37
35.34
Days Sales Outstanding 20.83
CAH's Days Sales Outstanding is ranked higher than
94% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 60.84 vs. CAH: 20.83 )
Ranked among companies with meaningful Days Sales Outstanding only.
CAH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 19.16  Med: 21.73 Max: 23.22
Current: 20.83
19.16
23.22
Days Payable 53.71
CAH's Days Payable is ranked lower than
65% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 62.55 vs. CAH: 53.71 )
Ranked among companies with meaningful Days Payable only.
CAH' s Days Payable Range Over the Past 10 Years
Min: 35.78  Med: 44.33 Max: 54.93
Current: 53.71
35.78
54.93

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 3.47
CAH's Dividend Yield % is ranked higher than
72% of the 68 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.59 vs. CAH: 3.47 )
Ranked among companies with meaningful Dividend Yield % only.
CAH' s Dividend Yield % Range Over the Past 10 Years
Min: 0.74  Med: 2.01 Max: 3.49
Current: 3.47
0.74
3.49
Dividend Payout Ratio 0.35
CAH's Dividend Payout Ratio is ranked higher than
80% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.28 vs. CAH: 0.35 )
Ranked among companies with meaningful Dividend Payout Ratio only.
CAH' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.22  Med: 0.37 Max: 1.12
Current: 0.35
0.22
1.12
3-Year Dividend Growth Rate 13.10
CAH's 3-Year Dividend Growth Rate is ranked higher than
57% of the 28 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.70 vs. CAH: 13.10 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
CAH' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 10.8  Med: 18.6 Max: 51.8
Current: 13.1
10.8
51.8
Forward Dividend Yield % 3.57
CAH's Forward Dividend Yield % is ranked higher than
68% of the 69 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.45 vs. CAH: 3.57 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 6.94
CAH's 5-Year Yield-on-Cost % is ranked higher than
68% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.97 vs. CAH: 6.94 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
CAH' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.49  Med: 4.04 Max: 7.02
Current: 6.94
1.49
7.02
3-Year Average Share Buyback Ratio 2.10
CAH's 3-Year Average Share Buyback Ratio is ranked higher than
88% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: -1.90 vs. CAH: 2.10 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CAH' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -38.9  Med: 0.6 Max: 5.7
Current: 2.1
-38.9
5.7

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 0.56
CAH's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
81% of the 26 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.53 vs. CAH: 0.56 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
CAH' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.3  Med: 1.29 Max: 8.9
Current: 0.56
0.3
8.9
Price-to-Median-PS-Value 0.79
CAH's Price-to-Median-PS-Value is ranked lower than
65% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.96 vs. CAH: 0.79 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CAH' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.52  Med: 1.48 Max: 3.38
Current: 0.79
0.52
3.38
Price-to-Peter-Lynch-Fair-Value 1.08
CAH's Price-to-Peter-Lynch-Fair-Value is ranked higher than
81% of the 16 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.23 vs. CAH: 1.08 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
CAH' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.49  Med: 1.35 Max: 5.26
Current: 1.08
0.49
5.26
Earnings Yield (Greenblatt) % 8.57
CAH's Earnings Yield (Greenblatt) % is ranked lower than
56% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.16 vs. CAH: 8.57 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CAH' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 6.5  Med: 8.8 Max: 20.8
Current: 8.57
6.5
20.8
Forward Rate of Return (Yacktman) % 20.76
CAH's Forward Rate of Return (Yacktman) % is ranked higher than
91% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.37 vs. CAH: 20.76 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
CAH' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 4.5  Med: 14.8 Max: 22.2
Current: 20.76
4.5
22.2

More Statistics

Revenue (TTM) (Mil) $134,426.00
EPS (TTM) $ 5.36
Beta1.12
Volatility27.61%
52-Week Range $50.79 - 80.37
Shares Outstanding (Mil)310.69

Analyst Estimate

Jun18 Jun19 Jun20
Revenue (Mil $) 135,940 141,053 146,172
EBIT (Mil $) 2,425 2,602 3,177
EBITDA (Mil $) 3,037 3,221 3,617
EPS ($) 5.06 5.54 6.25
EPS without NRI ($) 5.06 5.54 6.25
EPS Growth Rate
(Future 3Y To 5Y Estimate)
14.00%
Dividends per Share ($) 1.26 1.33 2.36

Piotroski F-Score Details

Piotroski F-Score: 77
Positive ROAY
Positive CFROAY
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyN
Higher Current Ratio yoyN
Less Shares Outstanding yoyY
Higher Gross Margin yoyY
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}